This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Zacks.com featured highlights include Terns Pharmaceuticals, AllianceBernstein Holding and ALLETE
by Zacks Equity Research
Terns Pharmaceuticals, AllianceBernstein Holding and ALLETE have been highlighted in this Screen of The Week article.
3 Stocks for Higher Returns as New Analysts Initiate Coverage
by Shrabana Mukherjee
Increased analyst coverage over the past few weeks may lead to solid price appreciation for stocks like Terns Pharmaceuticals (TERN), AllianceBernstein (AB) and ALLETE (ALE).
Lazard's (LAZ) August AUM Slips 3.6% on Market Depreciation
by Zacks Equity Research
Market depreciation, unfavorable FX movements and net outflows hurt Lazard's (LAZ) August AUM balance.
Invesco's (IVZ) August AUM Down on Unfavorable Market Returns
by Zacks Equity Research
Market depreciation, unfavorable FX movements and non-management fee-earning net outflows hurt Invesco's (IVZ) August AUM balance as it falls 2.3% from the prior month.
AllianceBernstein (AB) Stock Up 2.3% as July AUM Rises 6.5%
by Zacks Equity Research
Market appreciation and the acquisition of CarVal Investors aid AllianceBernstein's (AB) July AUM balance as it rises 6.5% from the prior month.
AllianceBernstein (AB) Gains As Market Dips: What You Should Know
by Zacks Equity Research
AllianceBernstein (AB) closed the most recent trading day at $43, moving +0.37% from the previous trading session.
AllianceBernstein (AB) Witnesses Marginal Rise in May AUM
by Zacks Equity Research
AllianceBernstein (AB) records month-end AUM of $687 billion in May 2022, up marginally from the end of the prior month.
Equitable Holdings (EQH) Cheers Investors With 11% Dividend Hike
by Zacks Equity Research
Based on the increased rate, Equitable Holdings' (EQH) annual dividend comes to 80 cents per share.
AllianceBernstein (AB) Stock Down as April AUM Declines 6.8%
by Zacks Equity Research
Dismal market performance and outflows lead to a decline in AllianceBernstein's (AB) April AUM balance.
Franklin Resources (BEN) Completes Lexington Partners Buyout
by Zacks Equity Research
Franklin (BEN) completes the acquisition of Lexington Partners L.P. in a cash deal of $1.75 billion to boost its alternative asset business.
Equitable Holdings (EQH) Arm to Acquire CarVal for $750M
by Zacks Equity Research
Equitable Holdings (EQH) expects the CarVal Investors acquisition to close in the second quarter of this year.
AllianceBernstein (AB) to Acquire CarVal Investors for $750M
by Zacks Equity Research
AllianceBernstein (AB) will strengthen private market capabilities and market position with the acquisition of CarVal, a global private alternatives investment manager, for $750 million.
AllianceBernstein (AB) February AUM Down on Unfavorable Markets
by Zacks Equity Research
AllianceBernstein's (AB) AUM balance for February declines on market depreciation, while net inflows offer some support.
AllianceBernstein (AB) January AUM Down on Market Depreciation
by Zacks Equity Research
AllianceBernstein's (AB) preliminary AUM for month-end January 2022 of $751 billion is down 3.6% from the previous month. The decline is mainly due to market depreciation.
Has AllianceBernstein (AB) Outpaced Other Finance Stocks This Year?
by Zacks Equity Research
Here is how AllianceBernstein (AB) and Assurant (AIZ) have performed compared to their sector so far this year.
Best Income Stocks to Buy for February 14th
by Zacks Equity Research
AB, TSE, and DHI made it to the Zacks Rank #1 (Strong Buy) income stocks list on February 14, 2022
New Strong Buy Stocks for February 14th
by Zacks Equity Research
LAD, PPC, TSE, AB, and AMAL have been added to the Zacks Rank #1 (Strong Buy) List on February 14, 2022.
Best Income Stocks to Buy for February 8th
by Zacks Equity Research
AB, SID, and VLO made it to the Zacks Rank #1 (Strong Buy) income stocks list on February 8, 2022
New Strong Buy Stocks for February 1st
by Zacks Equity Research
LEN, HZO, NUE, AB, and RHI have been added to the Zacks Rank #1 (Strong Buy) List on February 1, 2022.
Best Income Stocks to Buy for February 1st
by Zacks Equity Research
AB, SQM, and FRG made it to the Zacks Rank #1 (Strong Buy) income stocks list on February 1, 2022
Zacks.com featured highlights include: MEDIFAST, Children's Place Inc., Pool Corp., AllianceBernstein and Expeditors International of Washington
by Zacks Equity Research
MEDIFAST, Children's Place Inc., Pool Corp., AllianceBernstein and Expeditors International of Washington are included in this blog.
Here's Why AllianceBernstein (AB) Looks Ripe for Bottom Fishing
by Zacks Equity Research
AllianceBernstein (AB) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Is AllianceBernstein (AB) a Solid Growth Stock? 3 Reasons to Think " Yes "
by Zacks Equity Research
AllianceBernstein (AB) is well positioned to outperform the market, as it exhibits above-average growth in financials.
5 Top DuPont-Assured Quality Stocks to Beat Volatility
by Sanghamitra Saha
Bet on five top-ranked stocks with higher ROE derived the DuPont way.
AllianceBernstein (AB): Strong Industry, Solid Earnings Estimate Revisions
by Zacks Equity Research
AllianceBernstein (AB) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.